三氧化二砷和抗坏血酸在体外对原代慢性淋巴细胞白血病细胞显示出有前景的活性。
Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro.
机构信息
Division of Hematology and Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA.
出版信息
Leuk Res. 2010 Jul;34(7):925-31. doi: 10.1016/j.leukres.2010.01.020. Epub 2010 Feb 19.
Abstract
The compromised antioxidant defense system in chronic lymphocytic leukemia (CLL) suggested a potential use for reactive oxygen species (ROS) generating arsenic trioxide (ATO) and ascorbic acid. While both ATO and ascorbic acid mediate cytotoxicity in CLL B cells as single agents, the efficacy of ATO is enhanced by ascorbic acid. This effect is dependent on increased ROS accumulation, as pretreatment of B-CLL cells with a glutathione reducing buthionine sulfoximine or catalase inhibiting aminotriazole, enhanced ATO/ascorbic acid-mediated cytotoxicity. Pretreatment with reducing agents such as catalase, or thiol antioxidant, N-acetyl cysteine or GSH also abrogated ATO/ascorbic acid-mediated cytotoxicity. Furthermore, Hu1D10-mediated cell death was enhanced with ATO and ascorbic acid, thus justifying potential combination of ATO/arsenic trioxide therapy with antibodies such as Hu1D10 that also cause accumulation of ROS.
摘要
慢性淋巴细胞白血病 (CLL) 抗氧化防御系统受损，表明活性氧 (ROS) 生成三氧化二砷 (ATO) 和抗坏血酸可能具有潜在用途。虽然 ATO 和抗坏血酸作为单一药物均可介导 CLL B 细胞的细胞毒性，但抗坏血酸可增强 ATO 的功效。这种作用依赖于 ROS 积累的增加，因为用谷胱甘肽还原剂丁硫氨酸亚砜或过氧化氢酶抑制剂氨基三唑预处理 B-CLL 细胞可增强 ATO/抗坏血酸介导的细胞毒性。用过氧化氢酶或硫醇抗氧化剂、N-乙酰半胱氨酸或 GSH 等还原剂预处理也可消除 ATO/抗坏血酸介导的细胞毒性。此外，用 ATO 和抗坏血酸增强了 Hu1D10 介导的细胞死亡，因此有理由将 ATO/三氧化二砷治疗与 Hu1D10 等抗体联合使用，Hu1D10 也会导致 ROS 的积累。
相似文献
1
Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro.三氧化二砷和抗坏血酸在体外对原代慢性淋巴细胞白血病细胞显示出有前景的活性。
Leuk Res. 2010 Jul;34(7):925-31. doi: 10.1016/j.leukres.2010.01.020. Epub 2010 Feb 19.
2
Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.三氧化二砷通过增加 ROS 水平和 GSH 耗竭诱导人肺成纤维细胞死亡。
Oncol Rep. 2012 Aug;28(2):749-57. doi: 10.3892/or.2012.1852. Epub 2012 Jun 6.
3
Induction of apoptosis in arsenic trioxide-treated lung cancer A549 cells by buthionine sulfoximine.丁硫氨酸亚砜胺对三氧化二砷处理的肺癌A549细胞凋亡的诱导作用
Mol Cells. 2008 Aug 31;26(2):158-64. Epub 2008 Jul 3.
4
Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and -dependent cytotoxic potentiation.丁硫氨酸亚砜胺和抗坏血酸对三氧化二砷诱导的卵巢癌细胞死亡的差异增强作用：氧化应激非依赖性和依赖性细胞毒性增强。
Int J Oncol. 2011 Jun;38(6):1731-9. doi: 10.3892/ijo.2011.986. Epub 2011 Mar 23.
5
Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.依他尼酸及其衍生物增强三氧化二砷处理的髓性白血病和淋巴瘤细胞中的细胞凋亡：谷胱甘肽 S-转移酶 p1-1 的作用。
Clin Cancer Res. 2012 Dec 15;18(24):6690-701. doi: 10.1158/1078-0432.CCR-12-0770. Epub 2012 Oct 18.
6
Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide.环氧二十碳三烯酸可降低三氧化二砷处理的癌细胞中活性氧水平、线粒体功能障碍、半胱氨酸天冬氨酸蛋白酶激活和细胞凋亡。
J Pharmacol Exp Ther. 2011 Nov;339(2):451-63. doi: 10.1124/jpet.111.180505. Epub 2011 Aug 16.
7
Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells.小白菊内酯和丁硫氨酸亚砜胺增强三氧化二砷对小鼠和人白血病细胞的细胞毒性作用
Cancer Chemother Pharmacol. 2008 Apr;61(5):727-37. doi: 10.1007/s00280-007-0527-3. Epub 2007 Jun 27.
8
Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism.抑制线粒体蛋白质翻译通过依赖活性氧的机制使黑色素瘤细胞对三氧化二砷的细胞毒性敏感。
Cancer Chemother Pharmacol. 2008 Dec;63(1):37-43. doi: 10.1007/s00280-008-0705-y. Epub 2008 Feb 23.
9
Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.三氧化二砷与L-丁硫氨酸亚砜胺联合治疗晚期实体瘤的疗效
Cell Death Differ. 2004 Jul;11(7):737-46. doi: 10.1038/sj.cdd.4401389.
10
Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.三氧化二砷诱导肝癌细胞系凋亡及其被丁硫氨酸亚砜胺增强的作用
Biochem Biophys Res Commun. 2002 Mar 8;291(4):861-7. doi: 10.1006/bbrc.2002.6525.
引用本文的文献
1
Vitamin C Supplementation in the Treatment of Autoimmune and Onco-Hematological Diseases: From Prophylaxis to Adjuvant Therapy.维生素 C 补充治疗自身免疫性和血液肿瘤疾病：从预防到辅助治疗。
Int J Mol Sci. 2024 Jul 2;25(13):7284. doi: 10.3390/ijms25137284.
2
Does each Component of Reactive Oxygen Species have a Dual Role in the Tumor Microenvironment?活性氧物质的每个组成部分在肿瘤微环境中都具有双重作用吗？
Curr Med Chem. 2024;31(31):4958-4986. doi: 10.2174/0929867331666230719142202.
3
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer.大剂量静脉注射维生素 C，一种有前途的癌症多靶点治疗药物。
J Exp Clin Cancer Res. 2021 Oct 30;40(1):343. doi: 10.1186/s13046-021-02134-y.
4
Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia.抗坏血酸（维生素 C）协同增强慢性淋巴细胞白血病的靶向治疗疗效。
J Exp Clin Cancer Res. 2020 Oct 28;39(1):228. doi: 10.1186/s13046-020-01738-0.
5
Ascorbic Acid Sensitizes Colorectal Carcinoma to the Cytotoxicity of Arsenic Trioxide Promoting Reactive Oxygen Species-Dependent Apoptosis and Pyroptosis.抗坏血酸使结肠直肠癌对三氧化二砷的细胞毒性敏感，促进活性氧依赖性凋亡和焦亡。
Front Pharmacol. 2020 Feb 21;11:123. doi: 10.3389/fphar.2020.00123. eCollection 2020.
6
Synthesis and Evaluation of Folate-Conjugated Phenanthraquinones for Tumor-Targeted Oxidative Chemotherapy.用于肿瘤靶向氧化化疗的叶酸共轭菲醌的合成与评价
Open J Med Chem. 2016 Mar;6(1):1-17. doi: 10.4236/ojmc.2016.61001. Epub 2016 Mar 11.
7
Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden.有机金属核苷诱导非经典白血病细胞死亡，这种死亡依赖于线粒体活性氧，并由TCL1癌基因负荷促进。
Mol Cancer. 2015 Jun 4;14:114. doi: 10.1186/s12943-015-0378-1.
8
Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia.金诺芬诱导致命的氧化应激和内质网应激，并对慢性淋巴细胞白血病发挥强大的临床前活性。
Cancer Res. 2014 May 1;74(9):2520-32. doi: 10.1158/0008-5472.CAN-13-2033. Epub 2014 Mar 5.
9
Arsenic trioxide induces apoptosis in B-cell chronic lymphocytic leukemic cells through down-regulation of survivin via the p53-dependent signaling pathway.三氧化二砷通过 p53 依赖的信号通路下调生存素诱导 B 细胞慢性淋巴细胞白血病细胞凋亡。
Leuk Res. 2013 Dec;37(12):1719-25. doi: 10.1016/j.leukres.2013.09.019. Epub 2013 Sep 29.
10
Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.氧化还原调控与白血病：从分子机制到治疗机遇。
Antioxid Redox Signal. 2013 Apr 10;18(11):1349-83. doi: 10.1089/ars.2011.4258. Epub 2012 Sep 28.
本文引用的文献
1
Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13.三氧化二砷优先诱导具有包括17p13缺失等不良预后因素的慢性淋巴细胞白血病（B-CLL）患者的细胞凋亡。
J Mol Med (Berl). 2008 May;86(5):541-52. doi: 10.1007/s00109-008-0314-6. Epub 2008 Feb 23.
2
Vitamin C protects HL60 and U266 cells from arsenic toxicity.维生素C可保护HL60和U266细胞免受砷毒性的影响。
Blood. 2005 May 15;105(10):4004-12. doi: 10.1182/blood-2003-03-0772. Epub 2005 Jan 27.
3
The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds.甲基化砷化合物在内皮细胞中的积累与毒性：硫醇化合物的重要作用。
Toxicol Appl Pharmacol. 2004 Aug 1;198(3):458-67. doi: 10.1016/j.taap.2003.10.023.
4
Extramedullary relapse in a patient with acute promyelocytic leukemia: successful treatment with arsenic trioxide, all-trans retinoic acid and gemtuzumab ozogamicin therapies.一名急性早幼粒细胞白血病患者的髓外复发：三氧化二砷、全反式维甲酸和吉妥单抗奥唑米星治疗成功
Leuk Res. 2004 Sep;28(9):991-4. doi: 10.1016/j.leukres.2004.01.004.
5
Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells.NADPH氧化酶在砷诱导的髓系白血病细胞活性氧生成及细胞毒性中的作用
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4578-83. doi: 10.1073/pnas.0306687101. Epub 2004 Mar 15.
6
Arsenite sensitizes human melanomas to apoptosis via tumor necrosis factor alpha-mediated pathway.亚砷酸盐通过肿瘤坏死因子α介导的途径使人类黑色素瘤对细胞凋亡敏感。
J Biol Chem. 2004 May 21;279(21):22747-58. doi: 10.1074/jbc.M314131200. Epub 2004 Mar 17.
7
Oxidative mechanism of arsenic toxicity and carcinogenesis.砷毒性和致癌作用的氧化机制。
Mol Cell Biochem. 2004 Jan;255(1-2):67-78. doi: 10.1023/b:mcbi.0000007262.26044.e8.
8
Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者血清中谷胱甘肽过氧化物酶、谷胱甘肽还原酶、铜锌超氧化物歧化酶活性、谷胱甘肽、一氧化氮和丙二醛浓度
Clin Chim Acta. 2003 Dec;338(1-2):143-9. doi: 10.1016/j.cccn.2003.08.013.
9
Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells.Hu1D10在人慢性淋巴细胞白血病细胞中诱导细胞凋亡的同时激活AKT生存通路。
Blood. 2004 Mar 1;103(5):1846-54. doi: 10.1182/blood-2003-08-2836. Epub 2003 Nov 20.
10
The molecular mechanism of arsenic trioxide-induced apoptosis and oncosis in leukemia/lymphoma cell lines.三氧化二砷诱导白血病/淋巴瘤细胞系凋亡和胀亡的分子机制。
Acta Haematol. 2003;110(1):1-10. doi: 10.1159/000072407.
Zotero 插件